Bolzati et al.
ppm): δ 218.77 (CS2), 50.26 and 49.88 (s + s, NCH2CH2), 35.95 [d,
2JPC ) 6.8 Hz, SCH2CH2P], 34.76, 34.36, 33.95, 33.59 29.68, 29.21,
27.99, 27.48, 27.05, 26.92, 26.52, 26.00, 25.73, 24.86, 24.72.
[Re(N)(PScy)(L3)] (Re7): Yellow crystals of Re7·1/2H2O suit-
able for X-ray studies were obtained by slow diffusion of n-hexane
into a CH2Cl2 solution of the compound. Yield 73%. Anal. Calcd
for C20H36N2PS3Re (MW 618.13): C 38.86, H 5.87, N 4,55, S 15.56.
Found: C 38.67, H 6.01, N 4.60, S 15.85.
product was identified as the pure [Tc(N)(PS)2] compound (yield
≈ 80%) and the second yellow complex as the oxidized derivative
(yield < 10%).
For method b, to 0.092 mmol of [Tc(N)Cl2(PPh3)2] suspended
in CH2Cl2 (5 mL) was added 0.928 mmol of the selected PSH ligand
dissolved in EtOH (5 mL). The reaction mixture was stirred at reflux
under dinitrogen atmosphere overnight. After cooling, the solvents
were removed by gentle dinitrogen stream, and the residue was
treated with n-hexane. A yellow precipitate was collected by
filtration. The solid was dissolved in CHCl3 and loaded onto a silica
column previously conditioned with CHCl3. The column was eluted
with CHCl3, and two yellow bands were separated and collected.
The eluate was evaporated, and the residues were treated with Et2O
to yield the complexes. The first yellow product was identified as
[Tc(N)(PS)Cl(PPh3)] (vide infra) and the second yellow complex
as [Tc(N)(PS)2] (yields 60-80%).
FT-IR (KBr, cm-1): [1073 ν(Ret N)], [2913-2849 ν(H-Cy)],
[1522 ν(S2CN<)].
1
31P NMR (CDCl3 ppm): δ 84.6 (s). H NMR (CDCl3 ppm): δ
4.08 and 3.76 (m + m, 2H + 2H, N[CH2CH2]2CH2), 2.91 (m, 2H,
SCH2CH2P), 2.21-1.04 (22H + 2H + + 2H + 4H, CyP,
13
SCH2CH2P and N[CH2CH2]2CH2).
C NMR (CDCl3 ppm): δ
2
224.08 (CS2), 49.07 and 48.24 (s + s, NCH2CH2), 35.80 [d, JPC
) 6.8 Hz, SCH2CH2P], 34.72, 34.31, 33.88, 33.53 29.26, 29.21,
27.88, 27.44, 27.03, 26.92, 26.56, 26.00, 25.73, 25.66, 24.48, 23.91.
[Re(N)(PSiso)(L2)] (Re8): Yield 65%. Anal. Calcd for
C13H26N2PS3Re (MW 524.05): C 29.79, H 5.00, N 5,34, S 18.35.
Found: C 29.07, H 5.07, N 5.40, S 18.80.
[Tc(N)(PSme)2] (Tc11): Yield 60%. Anal. Calcd for
C8H20P2S2NTc (M.W 354.95): C 27.07, H 5.67, N 3.94, S 9.03.
Found: C 27.92, H 5.40, N 3.51, S 9.50. FT-IR (KBr, cm-1): [1066
(ν Tct N)], [2950-2867 ν(H-alkyl)].
FT-IR (KBr, cm-1): [1072 ν(Ret N)], [2952-2868 ν(H-alkyl)],
[1508 ν(S2CN<)].
31P NMR (CDCl3 ppm): δ 48.9 (bs). H NMR (CDCl3 ppm): δ
1
1.57 [m, 12H P(CH3)2], 2.08 and 2.01 [m, 2H + 2H, SCH2CH2P],
2.89 [m, 4H, SCH2CH2P].
13C NMR (CDCl3 ppm):
δ 35.90 [SCH2CH2P], 28.79
31P NMR (CDCl3 ppm): δ 94.0(s). H NMR (CDCl3 ppm): δ
1
3.83 (m, 4H, N[CH2CH2]2), 2.85 (m, 2H, SCH2CH2P), 2.30 (m,
1H + 1H, PCH(CH3)2), 2.08 (m, 4H, N[CH2CH2]2), 1.91 and 1.52
(m+m,1H+1H,SCH2CH2P),1.30-0.91(6H+6H,PCH(CH3)2).ESI-
MS(+) (m/z): 547 [M + Na]+ (100%), 525 [M + H]+ (20%).
[Re(N)(PSiso)(L4)] (Re9): Yellow crystals of Re9 suitable for
X-ray studies were obtained by slow diffusion of n-hexane into a
CH2Cl2 solution of the compound. Anal. Calcd for C15H31N3PS3Re
(MW 567.09): C 31.77, H 5.51, N 7,41, S 16.96. Found: C 31.27,
H 5.50, N 7.49, S 17.32.
[SCH2CH2P], 17.15 and 11.11 [P(CH3)2].
[Tc(N)(PSiso)2] (Tc12): Yield 81%. Anal. Calcd for
C16H36NP2S2Tc (MW 467.59): C 41.10, H 7.76, N 3.01, S 13.71.
Found C 40.84, H 7.44, N 2.81, S 13.92.
FT-IR (KBr, cm-1): [1065 (ν Tct N)], [2928-2869 ν(H-alkyl)].
1
31P NMR (CDCl3 ppm): 98.8 (bs). H NMR (CDCl3 ppm): δ
0.82 [m, 6H, PCH(CH3)2], 1.25 [m, 12H, PCH(CH3)2], 1.44 [m,
6H, PCH(CH3)2], 1.89 and 2.10 (2H + 2H, PCH(CH3)2], 2.47 (m,
4H, (SCH2CH2P)], 2.94 [m, 4H, SCH2CH2P].
[Tc(N)(PSibu)2] (Tc13): Yield 76%. Anal. Calcd for
C20H44NP2S2Tc (MW 523.70): C 45.87, H 8.68, N 2.68, S 12.24.
Found C 46.97, H 8.98, N 2.56, S 13.24.
FT-IR (KBr, cm-1): [1048 (ν Tct N)], [2954-2867 ν(H-alkyl)].
31P (CDCl3 ppm): 66.7 (bs). 1H NMR (CDCl3 ppm): δ 2.99 and
2.67 [m, 2H + 2H, (SCH2CH2P)], 2.32 and 2.05 [m, 2H + 2H,
PCH2CH(CH3)2], 2.25 and 2.01 [m, 2H + 2H, SCH2CH2P], 1.95
and 1.55 [m, 4H + 4H, PCH2CH(CH3)2], 1.15, 1.08, 1.05 and 0.96
[4d, 6H + 6H + 6H + 6H, (CH3)2CHCH2P]. 13C NMR (CDCl3
ppm): δ 35.56 and 32.54 [SCH2CH2P], 33.15 [PCH2CH(CH3)2],
28.37 [SCH2CH2P], 26.58 and 25.04 [PCH2CH(CH3)2], 25.61- 24.54
[PCH2CH(CH3)]. ESI-MS(+) (m/z): 1069 [2M + Na]+ (52%), [(2M
+ H) - PSibu]+ (72%), 524 [M + H]+ (100%).
FT-IR (KBr, cm-1):[1072 ν(Ret N)], [2958-2810 ν(H-alkyl)],
[1524 ν(S2CN<)].
1
31P NMR (CDCl3 ppm): δ 94.1 (s). H NMR (CCl3 ppm): δ
4.11 and 3.84 (m + m, 2H + 2H, N[CH2CH2]2NCH2CH3), 2.85
(m, 2H, SCH2CH2P), 2.58 (m, 4H, N[CH2CH2]2NCH2CH3), 2.48
(q, 2H, N[CH2CH2]2NCH2CH3), 2.32 (m, 1H + 1H, PCH(CH3)2),
1.92 and 1.53 (m + m, 1H + 1H, SCH2CH2P), 1.39-0.89 (6H +
6H + 3H, PCH(CH3)2 and N[CH2CH2]2NCH2CH3).
13C NMR (CDCl3 ppm): δ 228.26 (CS2), 51.86, 51.79, 51.62,
2
47.77, 46.92, 36.26 [d, JPC ) 6.6 Hz, SCH2CH2P], 27.55, 27.11,
25.73, 25.33, 24.36, 23.99, 19.33, 17.56, 11.93.
ESI-MS(+) (m/z): 590 [M + Na]+ (26%), 568 [M + H]+ (52%),
547 [M + Na - CH(CH3)2]+ (100%).
Mixed-substituted complexes are soluble in chlorinated solvents,
MeCN, and alcohols and insoluble in n-hexane, Et2O, and water.
Synthesis of Bis-substituted Complexes. [Tc(N)(PS)2]
[Tc(N)(PSibu)(OPSibu)] (Tc13a): Yield < 10%. Anal. Calcd
for C20H44NP2S2Tc (MW 668.203): C 57.52, H 6.18, N 2.1, S 5.22.
Found C 53.84, H 6.44, N2.81, S 5.22.
(Tc11-14) (PS
)
PSme, PSiso, PSibu, PStbu) and
[Tc(N)(PSibu)(OPSibu)] (Tc13a). For method a, to 0.194 mmol
of the selected PSH ligand dissolved in degassed EtOH (5 mL)
were added ten drops of TFA (10% v/v) followed by 0.05 mmol
of [(AsPh4)Tc(N)Cl4] dissolved in CH2Cl2 (2 mL). The reaction
mixture was stirred at reflux under dinitrogen atmosphere for 2 h
during which the solution became yellow-brown. The solvents were
removed by gentle dinitrogen stream, and the crude product was
treated with Et2O. Column chromatography was necessary to
separate pure species. The residue was dissolved in CHCl3 and
loaded onto a silica column previously conditioned with CHCl3.
The column was eluted with CHCl3 and two yellow bands were
separated and collected. The eluate was evaporated, and the residues
were treated with Et2O to yield the complexes. The first yellow
FT-IR (KBr, cm-1): [1053 (ν Tct N)], [2957-2869 ν(H-alkyl)].
2
31P NMR (CDCl3 ppm): δ 65.5 (bs), 46.3 (d, JPP ) 134 Hz).
1H NMR (CDCl3 ppm): δ 3.62 (m, 1H), 2.96 (m, 1H), 2.75 (m,
1H + 1H), 2.32-1.70 [8H], 2.20 (m, 2H + 1H), 2.13 (m, 1H),
1.93 (m, 1H), 1.77 (m, 1H + 1H), 1.41 (dt, 1H), 1.10 (m, 18H),
1.00 (dd, 6H).
[Tc(N)(PStbu)2] (Tc14): Yield 80%. Anal. Calcd for
C20H44NP2S2Tc (MW 523.70): C 45.87, H 8.68, N 2.68, S 12.24.
Found: C 45.97, H 8.83, N 2.60, S 13.11.
FT-IR (KBr, cm-1): [1062 (ν Tct N)], [2967-2863 ν(H-alkyl)].
31P NMR (CDCl3 ppm): δ 109.0 (bs). 1H NMR (CDCl3 ppm): δ
3.12-2.87 [4H, (SCH2CH2P)], 2.26-2.02 [4H, (SCH2CH2P)], 1.51
and 1.22 [m, 18H, PC(CH3)3]. 13C NMR (CDCl3 ppm): δ 34.96
11976 Inorganic Chemistry, Vol. 47, No. 24, 2008